Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1631
This examiner grants 45% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17540723 | OBTURATOR, METHODS OF FORMING A PREFABRICATED, INNERVATED, PRE-VASCULARIZED, PRELAMINATED (PIPP) FLAP USING AN OBTURATOR TO MAINTAIN A STOMA OR LUMEN, AND METHODS OF RESTORING DAMAGED OR SURGICALLY-REMOVED SOFT TISSUE WITH A PIPP FREE OR ROTATIONAL FLAP | Final Rejection | The Regents of The University of Michigan |
| 17272203 | ADENO-ASSOCIATED VIRAL VECTORS FOR THE TREATMENT OF BEST DISEASE | Non-Final OA | University of Florida Research Foundation, Incorporated |
| 17281853 | METHODS FOR THE EXPANSION OF MESENCHYMAL STROMAL CELLS | Non-Final OA | Board of Regents, The University of Texas System |
| 17485846 | METHODS AND APPARATUS FOR CONDITIONING CELL POPULATIONS FOR CELL THERAPIES | Final Rejection | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
| 18233146 | CELL EXPANSION SYSTEM | Non-Final OA | Terumo BCT, Inc. |
| 18892177 | METHODS FOR CREATING LINKAGE OF MULTIPLE VIRAL VECTORS FOR INTRACELLULAR DELIVERY | Non-Final OA | Battelle Memorial Institute |
| 17602730 | METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS | Non-Final OA | The Trustees of the University of Pennsylvania |
| 17424140 | MICROENVIRONMENT SENSORS TO REGULATE ENGINEERED GENE EXPRESSION | Final Rejection | Seattle Children's Hospital (dba Seattle Children's Research Institute) |
| 18161467 | CELLULAR REPROGRAMMING OF HUMAN ADIPOCYTES | Final Rejection | MIAMI UNIVERSITY |
| 18015042 | TRANSGENIC MOUSE MODELS SUPPORTING HUMAN INNATE IMMUNE FUNCTION | Final Rejection | The Jackson Laboratory |
| 17740665 | METHODS OF MINIMIZING NEUROTOXICITY ASSOCIATED WITH CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPY | Non-Final OA | Legend Biotech USA Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy